“Remdesivir does not improve mortality. It has serious toxicity to it. Everyone should be asking, 'Why do hospitals stock and use Remdesivir...
Remdesivir was too unethical to put into Ebola clinical trials in Africa because it had a 53% kll rate published in medical...
Patients denied medication reconciliation and shared decision making. Oral generics started early much safer and more effective approach than financially incentivized Remdesivir.
Recent Comments